| Literature DB >> 28446190 |
Tamirat Gebru1,2,3,4,5, Anthony Ajua1,2, Michael Theisen6,7, Meral Esen1,2,3,4, Ulysse Ateba Ngoa1,2,3,4,8, Saadou Issifou1,2,9, Ayola A Adegnika1,2,3,4,8, Peter G Kremsner1,2,3,4, Benjamin Mordmüller1,2,3,4, Jana Held10,11,12,13.
Abstract
BACKGROUND: Transmission of malaria from man to mosquito depends on the presence of gametocytes, the sexual stage of Plasmodium parasites in the infected host. Naturally acquired antibodies against gametocytes exist and may play a role in controlling transmission by limiting the gametocyte development in the circulation or by interrupting gamete development and fertilization in the mosquito following ingestion. So far, most studies on antibody responses to sexual stage antigens have focused on a subset of gametocyte-surface antigens, even though inhibitory Ab responses to other gametocyte antigens might also play a role in controlling gametocyte density and fertility. Limited information is available on natural antibody response to the surfaces of gametocyte-infected erythrocytes.Entities:
Keywords: Ascaris lumbricoides; Clinical isolates; GMZ2; Helminths; Immune modulation; Malaria; Plasmodium falciparum; Transmission blocking; Trichuris trichiura
Mesh:
Substances:
Year: 2017 PMID: 28446190 PMCID: PMC5406886 DOI: 10.1186/s12936-017-1827-7
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Study name, background characteristics, grouping, hematological profiles and time of data collection of samples used within the study
| Study identifier (population) | Sampling period (month/year) | No. of participants | Median age in years (range) | Mean hemoglobin (g/dL) | Vaccine allocation | Samples time points |
|---|---|---|---|---|---|---|
| GMZ2_3_08 | 09/2008–10/2009 | 30 | 3.5 (1–5) | 10.5 | GMZ2 100 µg | Days 0 and 84 |
| GMZ2_2_07 | 07/2007–08/2008 | 32 | 26.3 (18–45) | 13.8 | GMZ2 100 µg | Days 0 and 84 |
Fig. 1Antibody response to in vitro differentiated live, fixed or permeabilized Plasmodium falciparum gametocytes. The figure shows the flow cytometric data obtained using live, fixed or permeabilized gametocyte-infected erythrocytes. Dots represent percentage positive cells (erythrocytes positive for AlexaFluor-488), one dot per tested sample. Gates were set against controls, which are serum from malaria naïve individuals. NF non fixed, NP non permeabilized, F fixed, P permeabilized. The Y-axis shows percentage of erythrocytes positive for the used marker (Alexa.Fluor-488)
Fig. 2Microscopic IFA of antibody response to P. falciparum gametocytes. The figures show an example picture of AlexaFluor-488 stained parasites by fluorescence microscopy before (a) and after (b) permeabilization
Fig. 3Baseline levels of antibody response to gametocytes of P. falciparum in semi-immune adults and malaria exposed children. Antibody response (percentage of positive cells) against in vitro developed matured gametocytes (P. falciparum NF54 strain) of the serum samples of the different trials conducted in Gabon (GMZ2 children on Day 0 [36] and GMZ2 adults on Day 0 [37]) at baseline. Median, 25th and 75th percentiles, and minimum and maximum ranges are indicated
Fig. 4Effect of GMZ2 vaccination on the development of antibody response to mature P. falciparum gametocytes. a, b Show the antibody response in semi-immune adults and malaria-exposed children, respectively. In adults, 73.3% (11/15) show a decrease of Ab response after vaccination while 20% (3/15) show an increase and one person has shown no change (6.7%). D0 Day 0, D84 Day 84, GMZ2 100 µg or GMZ2 30 µg: participants who received 100 or 30 µg of GMZ2 vaccine, respectively. Rabies: participants who received the control rabies vaccine
Spearman correlation of the antibody response to sexual stage antigens with asexual stage antigens and the GMZ2 vaccine antigen of P. falciparum in adults/children from Gabon
| Study participants and vaccination | Antibody against whole asexual stage antigens by C-IFA (Mean PPFC) | Antibody against GMZ2 by ELISA (Mean Ab titers) |
|---|---|---|
| Rho (95% CI) | Rho (95% CI) | |
| Antibody against stage V gametocytes by C-IFA (Mean PPFC) | ||
| Adults | ||
| D0a | 0.39 (0.03, 0.66)* | 0.17 (−0.18, 0.48) |
| D84 (GMZ2) | 0.41 (−0.17, 0.78) | 0.44 (−0.13, 0.80) |
| D84 (Rabies) | 0.40 (−0.21, 0.79) | 0.54 (−0.03, 0.85) |
| Children | ||
| D0a | 0.16 (−0.24, 0.51) | 0.28 (−0.11, 0.60) |
| D84 (GMZ2, 30 µg dose) | 0.02 (−0.62, 0.64) | −0.10 (−0.69, 0.57) |
| D84 (GMZ2, 100 µg dose) | 0.06 (−0.59, 0.67) | 0.22 (−0.48, 0.75) |
| D84 (Rabies) | −0.27 (−0.77, 0.44) | 0.22 (−0.48, 0.75) |
C-IFA Cytometric immunofluorescence assay, ELISA Enzyme-linked immunosorbent assay, PPFC percent positive fluorescent cells, CI Confidence interval
Significant p value is indicated as follows: * P < 0.05
a D0 Values represent both GMZ2 and Rabies groups together. D0 Day 0, D84 Day 84
Fig. 5Antibody response to P. falciparum mature gametocytes in children from Gabon infected with intestinal parasites. The x-axis shows helminth infection status on Day 0 before vaccination in children, N = 30. a, b show antibody recognition of live and permeabilized gametocyte infected erythrocytes, respectively. Y-axis shows percentage of erythrocytes positive for AlexaFluor-488. PPFC % positive fluorescent cells, IQR Interquartile range. Median and IQR are indicated